ReviveMed

ReviveMed Inc. Focuses on Discovering Treatments for Metabolic Diseases, Including Non-Alcoholic Fatty Liver Disease. ReviveMed has developed a unique approach that leverages artificial intelligence (AI) to utilize tens of thousands of metabolic data points for discovering new biology and the most impactful treatments. By employing our proprietary AI platform and metabolic data from patient tissues and biofluids, we identify treatments for metabolic diseases with unmet medical needs. As the database expands, it intelligently gains more insights into the manifestations of metabolic diseases and metabolic syndrome.